-
Emergent and Valneva's Zika vaccine clears phase 1
fiercepharma
December 11, 2018
A Zika vaccine candidate co-developed by Emergent BioSolutions and Valneva has turned up positive early-stage results, laying the groundwork for a potential technology transfer to Emergent.
-
Why China's flu vaccine supply is suffering this season
fiercepharma
December 11, 2018
It isn’t a scene one would expect after the world battled a severe flu season. But in China, supply of flu vaccines this season has come down...
-
Anti-vaccine sentiment causing first deaths, expert says
fiercepharma
December 11, 2018
In recent years, the anti-vaccine movement has gained steam and attracted a growing number of headlines. Now, a vaccine expert says the movement is starting to result in its first deaths.?
-
Citing low vaccine trust, experts warn of measles in Philippines
fiercepharma
December 11, 2018
Since Sanofi?disclosed?that its dengue vaccine Dengvaxia can cause more serious infections in certain people, distrust in vaccines has mounted in the Philippines...
-
J&J, Merck chip in for $100M U.K. vaccine center
fiercepharma
December 11, 2018
To help prepare the post-Brexit U.K.—and potentially the world—for future disease outbreaks, the U.K. government, with help from academic institutions and the pharma industry...
-
Panav Bio-Tech Introduces Classical Swine Fever
expressbpd
December 05, 2018
Himmvac Hog Cholera (T/C) Vaccine by Panav Bio-Tech is the vaccine that is made using Bovine Kidney Cell culture and provides protection against the Hog cholera or classical swine fever
-
FluGen’s broadly protective flu vaccine clears phase 1
fiercepharma
December 04, 2018
Every year, scientists have to choose which strains of flu virus to include in the coming season's flu shots, and when the vaccine strains don't match the circulating strains, vaccine effectiveness can be much lower.
-
NIH grants IDT 10-year vaccine manufacturing contract
fiercepharma
December 04, 2018
IDT Biologika has won a 10-year contract worth up to $80 million from the NIH’s National Institute of Allergy and Infectious Diseases to make vaccines and biologics for infectious diseases.
-
Most Bills Enacted Into Law Limit Vaccine Exemptions
drugs
November 30, 2018
Most proposed bills in state legislatures from 2011 to 2017 sought to expand access to immunization exemptions, but the majority of bills enacted into law limited exemptions......
-
DNAtrix, Valo Therapeutics Enter Strategic R&D Pact
contractpharma
November 28, 2018
DNAtrix?and?Valo Therapeutics?entered an exclusive R&D collaboration to develop enhanced vaccines using DNAtrix's clinical stage viruses and Valo's antigenic peptide technology.?
ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
Pharma Sources Insight July 2025
